![](/img/cover-not-exists.png)
Why and how immunohistochemistry should now be used to screen for the BRAFV600E status in metastatic melanoma? The experience of a single institution (LCEP, Nice, France)
Long, E., Ilie, M., Lassalle, S., Butori, C., Poissonnet, G., Washetine, K., Mouroux, J., Lespinet, V., Lacour, J.P., Taly, V., Laurent-Puig, P., Bahadoran, P., Hofman, V., Hofman, P.Volume:
29
Language:
english
Journal:
Journal of the European Academy of Dermatology and Venereology
DOI:
10.1111/jdv.13332
Date:
December, 2015
File:
PDF, 895 KB
english, 2015